Johnson & Johnson aim to target millennial parents through reintroducing its baby-care line

By Catherine Sturman
CNBC has recently reported that healthcare giant Johnson & Johnson are to relaunch its baby-care line, in its bid to target parents who want to util...

CNBC has recently reported that healthcare giant Johnson & Johnson are to relaunch its baby-care line, in its bid to target parents who want to utilise chemical-free products.

The line will be redesigned without unnecessary chemicals, such as sulphates, parabens and artificial fragrances, in a boost to drive up flagging sales, which have been declining by up to 20% since 2011.

The demand for more natural products is continuing to rise, and Johnson & Johnson is only too keen to take up the challenge.

See also

"Perhaps because of our success, we became a bit complacent and did not want to mess with success, for lack of a better expression," commented Jorge Mesquita, worldwide chairman and executive vice president for J&J's global consumer unit.

"Frankly, we failed to see evolving needs from millennial consumers, millennial moms, and we failed to evolve our model."

The company will therefore look at new opportunities to develop staple products for new mothers which are increasingly naturally sourced, and also invest in changing its packaging to make products more recyclable.

 

Share

Featured Articles

PA Consulting: People Want 'Stackable' Healthcare Products

PA Consulting report shows people want ‘stackable’ personalised healthcare products and services that leverage personal data

HIV Testing Landmark Highlights Ongoing AIDS Problems

As US healthcare solutions specialist RMI passes the 350-million HIV testing kit mark, we look at the current HIV/AIDS situation globally

Schneider's Blum on Electricity 4.0 and Healthcare

Olivier Blum, EVP of Schneider Electric’s Energy Management business tells Healthcare Digital how Electricity 4.0 can improve people's wellbeing

Research Breakthrough Promises New Lupus Treatments

Medical Devices & Pharma

Healthcare Systems Worldwide Hit by Global IT Outage

Technology & AI

Abbott Labs' profits soar; Nipro opens First US Facility

Medical Devices & Pharma